Tumor infiltrating lymphocytes (TILs) and their role in the immune response against cancer has been investigated for decades and it is now understood that cytotoxic CD8+ T-cells, otherwise known as “T-killer cells,” are essential components of a robust anti-tumor immune response. Here, CD8A is linked to neoplasm.